|
- 积分
- 3
- 威望
- 3
- 包包
- 15
|
A review of gene and stem cell therapy in cutaneous wound healing : f; ^+ |8 U0 U
A Stem Cell Niche for Intermediate Progenitor Cells of the Embryonic Cortex
0 J4 N5 o, e% g8 }Acute Complications of Stem Cell Transplant 6 d; e5 L7 n7 K( {7 c
Adhesion within the stem cell niches
8 G7 Z/ ~5 b' G/ D% ^Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma # W G5 p% C: t, O$ |1 D/ P
Beliefs About Science and News Frames in Audience Evaluations of Embryonic and Adult Stem Cell Research 7 o, Y7 w# T; q% h+ V3 ^
bone-What is the true nature of the osteoblastic hematopoietic stem cell niche ; y, ~& v1 v) A, B* j1 d
Apoptosis signaling in cancer stem cells 3 x3 |/ b. l7 O2 R* k
Nonmyeloablative and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation
: ?- c' a0 v2 y5 b0 o6 G' S7 qRecurrence cancer stem cells
+ L. k/ r4 @# L# E, vStem cells in melanoma development / ^! R3 q4 f4 ]. D. W
Competitive Interactions Between Cells W: a1 E* s+ y$ c
Cord blood stem cells for hematopoietic stem cell transplantation in the UK $ l7 E: j& m+ v( p- c
A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke
# |' L$ X1 I9 `5 K8 C UCardiac stem-progenitor cells, secreted proteins, and proteomics
' o; P! }" Q* N4 DCardiovascular stem cells in regenerative medicine
$ @1 ?1 S! }: D2 T9 h9 }Endogenous stem cells in patients undergoing coronary artery bypass
' Z/ W) b4 U0 ^, ]Enhancing cardiac stem cell differentiation into cardiomyocytes - k M% ?# K% v
In Vivo Imaging of Stem Cells and Beta Cells Using Direct Cell Labeling and Reporter Gene Methods
u/ e( W* ?, ` `% ?2 rResident cardiac stem-progenitor cells for cardiac regeneration
$ T& V- x+ P3 T7 VS1+ Stem Cell Survival and Engraftment in the Infarcted Heart
% ^1 U0 j# T2 jStem cell engineering for treatment of heart diseases
7 q2 g2 U3 q4 O, r& {Stem cell therapy in acute myocardial infarction
& W! Q$ t! q5 x, l/ B. `Stem Cell Therapy Is Proarrhythmic
' W/ l) j4 y4 T4 F# Q; o pStem Cell Therapy-A Primer for Interventionalists and Imagers O4 C1 @- K- W9 F
diabetes-Mesenchymal stem cells-Stem cell therapy perspectives for type 1 diabetes " J# V3 X# U7 h- [, s" d- N
Embryonic stem cells as a model for cardiac development and disease
, N: h: `- U) Z3 D# ^5 M1 lEpigenetic dynamics of stem cells and cell lineage commitment 5 V/ J" `) S; {2 v
Epileptic Spasms After Stem Cell Transplantation for Chronic Epstein-Barr Virus Infection : z. U" B/ w6 e: V, y) K3 R% o9 v
Expanding Indications for Stem Cell Transplantation
* Z# ?3 Z: s( Y( GFatal nephrotic syndrome complicating allogeneic stem cell transplantation " r; ]6 i3 @8 D( s
Growth Factors, Matrices, and Forces Combine and Control Stem Cells . @# ?8 j& J3 g- R
Hematopoietic stem cell origin of adipocytes / J3 z8 C! u; ^! [
Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis ) l0 @8 [+ l9 }2 t) c. y9 N+ {
Long-term microcarrier suspension cultures of human embryonic stem cells
) B. T- g( ?' iMicrosphere-based tracing and molecular delivery in embryonic stem cells
% k/ y: ^, U+ t9 b2 h/ d( GMicrospheres as a vehicle for biomolecule delivery to neural stem cells
) m$ v$ x7 z: `2 ENew insights into liver stem cells 3 _# N5 t; w- e, ~% I
A NEUROSURGEON'S GUIDE TO STEM CELLS, CANCER STEM CELLS, AND BRAIN TUMOR STEM CELLS
+ J) g7 C; r$ O$ k) M: J+ l; }Regeneration of the ischemic brain by engineered stem cells - R$ b; _- q2 o) A2 g- P
Stem cell-based cell replacement strategies for the central nervous system
5 c3 |2 i# f7 y& x1 J5 YPercutaneous intramyocardial stem cell injection in patients with acute myocardial infarction & r0 @6 |0 v5 D$ w9 k R
Peripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction
. ]6 g. m$ q" e g$ ]6 b% Y) n2 c5 E, PPluripotent stem cells as new drugs
; g7 d& k' F8 [ h2 ]regenerative-The complexity of cellular dedifferentiation-implications for regenerative medicine
1 s1 \# j5 R \ @' l ]* Zrespir-Cell therapy approaches for lung diseases
9 ?+ b3 B, H% } ?, J* A, c; ERisk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation 5 c) D& _9 [3 L2 A9 W
Role of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation % V5 b t" m1 R9 u; C! N3 Q; t$ o9 V
Role of Hematopoietic Stem Cell Transplant in the Management of Follicular Lymphoma
; B2 M7 S9 ]* L7 A- f; |, F6 TStatus of adult marrow stem cell biology & n1 D- [% ]. \% ^) n
Stem cell and genetic therapies for the fetus
% K! k# E( X* q# _Stem cell decision making and critical-like exploratory networks
9 I& S& c2 i1 c# ~6 N5 i. d. vStem Cell Therapy for Heart Failure
; a) P0 \' F6 ?9 ~Stem Cell Therapy for the Kidney # b+ T, Z$ {" i6 z- V4 `
Stem Cells and Liver Regeneration ; F) }# a2 h! s# L5 H/ i/ }# j
Stem cells, microenvironment mechanics, and growth factor activation
9 K! |' V5 N4 C- R- cStem cells-The highs and lows of pluripotency
' K0 a* Z' S) o3 p* TSuccessful unrelated donor stem cell transplantation for advanced myelofibrosis in an adult patient with history of orthotopic liver transplantation % R3 d7 i. R J& r# O
Survivorship Issues in Hematopoietic Stem Cell Transplantation
! l# m, ^+ j" D* NTelomere length maintenance in stem cell populations
4 r0 o1 @. G; p3 Q% jTeratoma formation by human embryonic stem cells . [3 M, q/ U- X) ~: s. ^
The Development of Inflammatory Arthritis and Other Rheumatic Diseases Following Stem Cell Transplantation
" ~3 j" ~ @- _7 CThe Increasing Complexity of the Cancer Stem Cell Paradigm 5 a/ M6 S8 F6 |( ^" ?% x
The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis
- D& f8 j+ }; d( j) y7 j* R RTranscripts of unknown function in multiple-signaling pathways involved in human stem cell differentiation + i- ?9 ?$ K" x% q
Variation in the safety of induced pluripotent stem cell lines
& v8 g: j, S0 r5 d. ?A niche play for stem cells , `& [, z+ t0 e. j
A niche play for stem cells
, j; _' ^8 `6 X; p0 U. c6 j$ [1 \" \5 UA parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells
4 p" l. J/ q, F: K) m- UAcute Complications of Stem Cell Transplant
7 l8 C0 D5 ?) hAdipose-Derived Stem Cells ) E( t6 l: a* E2 l3 ]: Z
Adult neural stem cells in the mammalian central nervous system
" P5 _+ {# w7 B7 IApoptosis Signaling in Cancer Stem Cells 1 c9 N; n* [& p9 _0 m% b/ z
Automated selection and collection of pluripotent stem cell colonies using the CellCelector " ?6 v4 B L, Z. G' |( {1 Y- k
BCOR regulates mesenchymal stem cell function by epigenetic mechanisms # |7 d3 ]1 t+ f: v
Bmi-1, stem cells and cancer
. A0 o5 U6 {9 K% Scancer stem cell marker
5 D4 j, W p! qCancer stem cells
" C8 x! [$ d: ]Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases 1 z# ]" ]5 _) |* j
Competitive Interactions Between Cells-Death, Growth, and Geography 4 g3 w( v5 R' D5 f5 E9 a
Potential novel pharmacological therapies for myocardial remodelling
8 p2 { v7 L: f3 E7 p8 ^" aDisease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells
( M+ k+ u% }& {6 ^Elite and stochastic models for induced pluripotent stem cell generation
$ z/ s7 d# s# d! F( kEmbryonic stem (ES) cell-derived cardiomyocytes 7 y5 `. Z- x( K! ~5 A* R% Q) t
Emerging Immunology of Stem Cell Transplantation , r/ [! X6 k" e6 A" A4 t* z! X
Ethical Issues in Stem Cell Research
) v' a4 C; }: NFDA Regulation of Stem Cell Based Products ; H. z& }) R4 U
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
1 `; v% c y* a0 w7 M5 E* d4 n! }Human embryonic stem cells and cardiac repair , v3 h' U2 F8 T( M5 L8 m
Human Fetal Membranes-A Source of Stem Cells for Tissue Regeneration and Repair
- v6 j- C6 H7 S% nHuman ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages
$ n% }8 _) i1 [6 \IFN-wakes up sleeping hematopoietic stem cells
$ ~9 O, c+ ]# mImaging Stem Cell Implant for Cellular-Based Therapies % \/ D0 Q+ \0 H0 Q
Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy
! k) M* g4 z4 x! T" M+ wInduced pluripotent stem cells and the stability of the differentiated state 2 i& ^% R/ x5 n8 J' p) h$ [/ t. Q3 F
Instructing an Embryonic Stem Cell-Derived Oocyte Fate
6 g! [4 h+ ]& Y$ w& KMedical Innovation Versus Stem Cell Tourism 8 [2 O* O/ L/ d3 G
In Search of Adrenocortical Stem and Progenitor Cells
/ q- c( p# z' g' _6 GNeural stem cells aplenty : i/ X& q8 r u6 R' H
Pancreatic cancer stem cells
1 d3 {/ l: v3 E- PParacrine Mechanisms in Adult Stem Cell Signaling and Therapy
X+ a6 Z8 d5 q( p$ PPsychological Issues of Stem Cell Transplant ) a0 o/ t9 I6 r+ p! e" e
Regeneration of the ischemic brain by engineered stem cells 6 D# j9 R9 t5 u) D8 M |
Regulatory circuits underlying pluripotency and reprogramming
- h6 J8 w# U0 qrespir-Cell therapy approaches for lung diseases ) l, F, {/ @' i1 B+ n- A
Role of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation 6 A" a$ t4 e# L
specific microRNAs promote induced pluripotency ' K0 |: S( U5 w9 B" N
Stem Cell Therapy for the Kidney
- E: e" Z/ t, r$ O7 X. c% V$ w9 Fstem cell therapy in cutaneous wound healing
/ V |/ K; S2 w) o P0 G% M: tStem cell therapy perspectives for type 1 diabetes
U' \, x, P1 V" v/ aStem Cells and Liver Regeneration ! b" k; t: k( j3 a
Stem cells based transplantation for cardiovascular diseases in China 2 b+ |6 _3 s' ~( B: W
Stem-cell therapy faces more scrutiny in China 8 W) \" e, W9 s* l8 ^
Steps to the Clinic
- }. x5 _6 @/ T" a5 o0 v8 ZStepwise differentiation of pluripotent stem cells into retinal cells ) G) V# c3 F1 k [
Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche / c) g7 ^0 b! e1 S6 y; ^* m
The Increasing Complexity of the Cancer Stem Cell Paradigm 8 [. {0 g/ C* G1 G0 u7 `1 d9 c
The NIH Draft Guidelines on Human Stem Cell Research & v2 o _5 n& z H x
The pluripotency factor Oct4 interacts with Ctcf and also controls X-chromosome pairing and counting # m( O( }! G" K3 [: I7 g- L
The Role of Stromal Stem Cells in Tissue Regeneration and Wound Repair
5 | K f! @ E- D6 bThe tumor stem cell concept
7 B- p$ @6 N" A! u8 SUmbilical cord blood stem cells-Towards a proteomic approach # `, C. F; _5 o# E5 i! }9 o' o
US regulator wades into stem cell therapies for heart disease
1 z) _1 L- ]% m$ O2 E" dApoptosis Signaling in Cancer Stem Cells
, ~7 T& U9 p" l9 R) o/ NPancreatic cancer stem cells , u: Z8 f+ V J0 y' `- w1 Q. s
Acute Complications of Stem Cell Transplant ; Z3 N L1 X* j3 v
Autologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma
" k2 `7 X- y* z3 q( Y. E3 v8 }Deconstructing Stem Cell Tumorigenicity-A Roadmap to Safe Regenerative Medicine
) B( b9 ]% n: G0 m9 b: R# aEmerging Immunology of Stem Cell Transplantation
0 K2 ]' T8 {" EManagement Issues In Hematopoietic Stem Cell Transplantation
- W4 k4 _8 X d- w( \: k# gPsychological Issues of Stem Cell Transplant 0 \6 X! j7 `- U f# |
The NIH Draft Guidelines on Human Stem Cell Research
" Q( B3 e3 h1 b- aThe therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis ; y( G* G8 r% r2 e2 ]
Bone Marrow-derived Stem-Progenitor Cells-Their Use in Clinical Studies for the Treatment of Myocardial Infarction / q. _8 `" ^; a! z6 L9 S
Embryonic stem (ES) cell-derived cardiomyocytes $ C, D6 M" H. T; f, O. W9 Y
Embryonic stem cells as a model for cardiac development and disease
6 S* b5 l' V& F5 P* I% m: D' X, NEndogenous stem cells in patients undergoing coronary artery bypass graft surgery
5 Y0 y L3 }9 U, h' |9 L- GHuman embryonic stem cells and cardiac repair
0 O/ y4 @; [8 B; n- qPercutaneous intramyocardial stem cell injection in patients with acute myocardial infarction
/ `+ z, c, T6 }/ d+ `Promise of Blood-and Bone Marrow-Derived Stem Cell Transplantation for Functional Cardiac Repair 7 \5 F$ ]# e, u9 |' e+ U- F% x
Stem Cell Therapy for Heart Failure - i0 f9 y1 K# e# A5 F& g
Epithelial metaplasia-adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation $ ]9 E4 Y' ~! Z* s- k2 }
Full text access provided to Peking university " t8 A0 o% k4 D& n8 M! s7 |
Improving stem cell mobilization strategies-future directions 7 ~1 H4 Q5 r2 a+ D+ m% k
Induced pluripotent stem cells from a spinal muscular atrophy patient
: O- J- R! _0 r1 N# ]% \% CInduced pluripotent stem cells-current progress and potential for regenerative medicine ( T/ r1 B; `. W8 x9 P" v0 d3 j
Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon鈥揹ependent exhaustion
* l3 u8 I$ i4 Q rLow-risk reprogramming
* o7 m1 O, o) d1 y5 {# j+ rMolecular cues for pluripotency, genetic reprogramming of adult stem cells, and widely multipotent adult cells N! G- `1 Z' i9 d
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells
: O9 ]$ {* N- N; YPluripotent stem cells as new drugs 6 a0 {& l$ d4 ^) H3 O- t) p$ Y
proteome-Umbilical cord blood stem cells-Towards a proteomic approach : w, o7 `7 _. E+ d" v
Regeneration of the ischemic brain by engineered stem cells 0 x7 T7 z: @- }
Researchers Generally Happy With Final Stem Cell Rules ; @& j* ?( E. _% Y
Stem Cell Niche
+ Z7 w6 f$ z3 q# ]2 S; ]: ]Stem cell therapy perspectives for type 1 diabetes - o. j4 t7 w; o! l
Stem Cells and Liver Regeneration 2 f+ h$ N3 o. v7 ^. A
Stem cells-Fast and furious
' m6 K5 h( F0 ?: g9 eSurvivorship Issues in Hematopoietic Stem Cell Transplantation % k2 _) R, J4 }* ~, G! D
The NIH Draft Guidelines on Human Stem Cell Research
! d& v: e- v2 h: eThe origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases
, E' q+ S9 F$ c/ vUS stem-cell research expands - ]3 F# n- c/ f a" H1 P8 g
Virus-free induction of pluripotency and subsequent excision of reprogramming factors
( h5 W1 {1 {! X( ^- dWnt Signaling, Lgr5, and Stem Cells in the Intestine and Skin |
|
发表于 2009-10-29 19:08
